Haleon Increases Chinese Stake
This is a China news story, published by Yahoo Finance, that relates primarily to Haleon news.
China news
For more China news, you can click here:
more China newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Haleon shares. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Chinese joint venture news, pharmaceutical companies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
partners Tianjin Pharmaceutical GroupReuters
•Sensodyne maker Haleon to raise stake in China JV
81% Informative
British consumer healthcare company Haleon plans to increase its stake in its Chinese joint venture to 88% from 55% .
Haleon will pay 4.47 billion yuan ( $637 million ) to buy the stake from partners Tianjin Pharmaceutical Group (TPG) An increasing number of Western firms are pulling back from China due to heightened geopolitical tensions and slowing economic growth.
VR Score
92
Informative language
97
Neutral language
87
Article tone
formal
Language
English
Language complexity
47
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links